Acumen Pharmaceuticals, Inc. — Investor Relations & Filings
Filings indexed
308
across all filing types
Latest filing
2026-05-12
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
ABOS
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted therapies for Alzheimer's disease. The company's approach is based on research into toxic soluble amyloid beta oligomers (AβOs), which are considered a primary driver of neurodegeneration associated with the disease. Its lead product candidate, sabirnetug (ACU193), is a monoclonal antibody designed to selectively target these toxic AβOs. Sabirnetug is being developed as a potential disease-modifying treatment for early Alzheimer's, with the goal of providing therapeutic benefits with an improved safety profile.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Acumen Pharmaceuticals, Inc. (0001576885) (Filer) | 2026-05-12 | English | |
| 8-K - Acumen Pharmaceuticals, Inc. (0001576885) (Filer) | 2026-05-12 | English | |
| 424B3 - Acumen Pharmaceuticals, Inc. (0001576885) (Filer) | 2026-04-01 | English | |
| S-8 - Acumen Pharmaceuticals, Inc. (0001576885) (Filer) | 2026-03-26 | English | |
| 8-K - Acumen Pharmaceuticals, Inc. (0001576885) (Filer) | 2026-03-26 | English | |
| 4 - ACUMEN PHARMACEUTICALS, INC. (0001576885) (Filer) | 2026-03-03 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45341748 | 10-Q - Acumen Pharmaceuticals, Inc. (0001576885) (Filer) | 2026-05-12 | English | ||
| 45234267 | 8-K - Acumen Pharmaceuticals, Inc. (0001576885) (Filer) | 2026-05-12 | English | ||
| 33150382 | 424B3 - Acumen Pharmaceuticals, Inc. (0001576885) (Filer) | 2026-04-01 | English | ||
| 33052041 | S-8 - Acumen Pharmaceuticals, Inc. (0001576885) (Filer) | 2026-03-26 | English | ||
| 33047337 | 8-K - Acumen Pharmaceuticals, Inc. (0001576885) (Filer) | 2026-03-26 | English | ||
| 32894292 | 4 - ACUMEN PHARMACEUTICALS, INC. (0001576885) (Filer) | 2026-03-03 | English | ||
| 30667365 | 4 Filing | 2026-01-28 | English | ||
| 30667379 | 4 Filing | 2026-01-23 | English | ||
| 30667376 | 4 Filing | 2026-01-23 | English | ||
| 30667372 | 4 Filing | 2026-01-23 | English | ||
| 30667366 | 4 Filing | 2026-01-23 | English | ||
| 30667364 | 4 Filing | 2026-01-23 | English | ||
| 30667405 | 4 Filing | 2026-01-21 | English | ||
| 30667404 | 4 Filing | 2026-01-21 | English | ||
| 30667382 | 4 Filing | 2026-01-21 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BIOCRYST PHARMACEUTICALS INC
Develops novel medicines for patients with rare and serious…
|
BCRX | US | Manufacturing |
|
Biocure Technology Inc.
Develops and commercializes advanced biological medicines, …
|
CURE.X | CA | Manufacturing |
|
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Develops novel antibody-based drugs and provides integrated…
|
2315 | HK | Manufacturing |
|
Biodexa Pharmaceuticals Plc
Clinical-stage biopharma developing treatments for rare dis…
|
BDRX | GB | Manufacturing |
|
BioDlink International Company Limited
Integrated biopharmaceutical CDMO specializing in ADC platf…
|
1875 | HK | Manufacturing |
|
BioEnvelop Technologies Corporation
Developed rapidly dissolving edible film strips for nutrace…
|
BIE | CA | Manufacturing |
|
Biofarm S.A.
A pharmaceutical company that manufactures and markets medi…
|
BIO | RO | Manufacturing |
|
BIO-FD&C CO.,LTD.
Develops active ingredients for cosmetics and pharma using …
|
251120 | KR | Manufacturing |
|
Biofil Chemicals & Pharmaceuticals
Produces pharmaceutical formulations, bulk drugs, and plast…
|
BIOFILCHEM | IN | Manufacturing |
|
Biofrontera AG
Biopharmaceutical firm specializing in photodynamic therapy…
|
B8F | DE | Manufacturing |
Acumen Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34208/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34208 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34208 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34208 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34208}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Acumen Pharmaceuticals, Inc. (id: 34208)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.